October 17, 2025

Where Renal Cancer Strikes Hardest – and Why the Numbers Are Climbing Fast

Global analysis reveals sharp rises in incidence, survival gaps across regions, and key genetic risk factors shaping diagnostics

The Pathologist

October 14, 2025

LDTs: The Hidden Engines of Precision Medicine

How LDTs give labs the agility to innovate beyond red tape – and deliver critical answers when patients need them most

The Pathologist

October 10, 2025

Seaport Criteria Bring Clarity to Myocarditis Grading

New guidelines combine hematoxylin and eosin and CD3 staining to improve diagnostic accuracy and reproducibility worldwide

The Pathologist

October 08, 2025

Tracking Residual Disease in Myeloma With Flow Cytometry

Multiparameter flow cytometry enables measurable residual disease testing and prognosis in patients with multiple myeloma

The Pathologist

October 07, 2025

Spatial Proteomics in Cancer Risk Predictions

AI-powered test enhances progression risk assessment in esophageal cancer

The Pathologist

September 30, 2025

Surrogates with Substance: Decoding Soft Tissue Tumors

Following a new CAP review, Jason L. Hornick discusses the strengths – and limitations – of IHC as a stand-in for molecular testing

The Pathologist

September 26, 2025

Prostate Cancer Screening Is Broken – How Do We Fix It?

Changing guidelines and flawed PSA thresholds have left men uncertain, but modern testing can restore confidence

The Pathologist

September 25, 2025

New Rules Aim to Standardize HRD Testing in Cancer Labs

Consensus recommendations standardize homologous recombination deficiency testing for clinical molecular laboratories

The Pathologist

September 24, 2025

Recent Advances in Treating Diffuse Large B-Cell Lymphoma

The disease we now call diffuse large B-cell lymphoma (DLBCL) has gone by the names of reticulum cell sarcoma, diffuse histiocytic lymphoma, and diffuse large cell lymphoma and included both lymphomas...

The ASCO Post